0001567619-21-005535.txt : 20210303
0001567619-21-005535.hdr.sgml : 20210303
20210303164157
ACCESSION NUMBER: 0001567619-21-005535
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vale Brad
CENTRAL INDEX KEY: 0001635670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36715
FILM NUMBER: 21709748
MAIL ADDRESS:
STREET 1: C/O NEVRO CORP.
STREET 2: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEVRO CORP
CENTRAL INDEX KEY: 0001444380
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 562568057
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-251-0005
MAIL ADDRESS:
STREET 1: 1800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
doc1.xml
FORM 4
X0306
4
2021-03-01
0
0001444380
NEVRO CORP
NVRO
0001635670
Vale Brad
C/O NEVRO CORP.
1800 BRIDGE PARKWAY
REDWOOD CITY
CA
94065
1
0
0
0
Common Stock
2021-03-01
4
S
0
503
166.0511
D
11831
D
Common Stock
2021-03-01
4
S
0
2012
167.0429
D
9819
D
Common Stock
2021-03-01
4
S
0
1278
168.3158
D
8541
D
Common Stock
2021-03-01
4
S
0
1510
169.0844
D
7031
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $165.49 to $166.405, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 1,376 restricted stock units.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $166.64 to $167.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $167.86 to $168.767, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $168.905 to $169.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Kashif Rashid, as Attorney-in-Fact for Brad Vale
2021-03-03